Objectives: To evaluate the correlation between lymphovascular space invasion (LVSI) indicating lower uterine segment involvement (LUSI) in endometrioid endometrial cancer and lymph node metastasis based on the lymphatic drainage difference between the uterine corpus and the lower segment.
INTRODUCTION
Although endometrial cancer ranks eighth among the most common 15 cancers in women in terms of incidence, it ranks 13th for mortality. This is because, in developing countries, these cases are usually diagnosed at an early stage; thus, the survival rates are high following primary surgery [1] . However, there are studies showing that lymphovascular space invasion (LVSI), defined as tumour cell accumulation in the lymphatic and blood vessels close to the invasive margin [2] , is an independent risk factor for lymph node metastasis, even in these early stage endometrial cancer cases [3] [4] [5] [6] . Nevertheless, unlike myometrial invasion and histological grade, which indicate the risk of lymph node metastasis, LVSI has not yet been identified as a predictive factor in endometrioid endometrial cancers that are limited to the uterus [7, 8] .
The characteristics of lymphatic drainage differ between the lower and the upper segments of the uterine corpus [9] .
This suggests that, in the case of endometrial cancer, the location of the tumour in the uterus might be a factor that may affect the correlation between the LVSI and lymph node metastasis. This is the first study to investigate the correlation of LUSI and LVSI with lymph node involvement.
Objectives
The aim of this study was to determine the effect of tumour location on the correlation between LVSI and lymph node metastasis in endometrioid endometrial cancer patients undergoing staging surgery.
MATERIAL AND METHODS
The hospital records of 376 patients undergoing staging surgery for the diagnosis of endometrial cancer between 1 January 2010 and 31 January 2019 were reviewed in this retrospective study. Ethics committee approval was obtained from our institution before the study started (11/2019).
The study included patients whose final pathology was representative of pure endometrioid endometrial cancer and who had the information about tumour size, LVSI, and lower uterine segment involvement (LUSI) in their pathology report. Patients with non-endometrioid endometrial cancer, a mixed type histology (≥ 10 non-endometrioid component), simultaneous malignancies, and with non-uterine metastasis in the intraoperative observational or frozen section examination were excluded from the study. Cases with less than 11 pelvic lymph nodes and less than 3 para-aortic lymph nodes in the pathology report, defined as an insufficient number of lymph nodes in the literature [10, 11] , were not included in the study (Fig. 1) .
Demographic data and the presence of diabetes proven by laboratory data (fasting plasma glucose of ≥ 126 or 2nd-hour plasma glucose of ≥ 200 after 75 mg of oral glucose) were obtained by reviewing the patient files [12] . Histologic type [13] and grade, [14] tumour size (≤ 2 cm or > 2 cm), myometrial invasion percentage (< 50% or ≥ 50%), [15] LUSI (present or absent), and LVSI (present or absent) findings defined by the World Health Organization (WHO) and the International Federation of Gynecology and Obstetrics (FIGO) criteria, number of lymph nodes removed and metastasis findings, peritoneal cytology finding (benign or malign),and adenomyosis finding were obtained by reviewing the pathology reports. The stage of the disease was determined according to the FIGO 2009 criteria [16] . Cancer antigen (CA)-125 levels determined by the Roche E170 Modular System chemiluminescence method were grouped according to the cut-off value (< 17.03 U/mL), which was chosen based on the laboratory reference value (< 35 U/mL) and the CA-125 mean value [17] . The LUSI and LVSI statuses of the cases along with patient age, lymph node metastatic involvement, tumour size, histological grade, CA-125 levels, presence of diabetes, and adenomyosis were compared.
LVSI was defined as the accumulation of tumour cells in the nearby lymphatic and blood vessels outside of the invasive margin [2] . LUSI was defined as the presence of tumour invasion in the lower quadrant of the uterine corpus [18] .
The data were expressed as mean ± standard deviation or number and percentage. The Chi-square and Fisher's exact test were used to compare the categorical data, while the One-Way ANOVA test was used for comparisons of more than two independent variables. If normally distributed, the non-categorical data were compared using the Student's t-test; if not, they were compared using the Mann-Whitney U test. All calculations were performed using SPSS (IBM Corp. Armonk, NY, USA) version 20.0 statistical software. A p value of < 0.05 was considered statistically significant.
RESULTS
The mean age of the 253 patients included in the study was 60.3 ± 9.8 years. The distribution of the number and mean age of the patients by LVSI, LUSI, and lymph node status is given in Table1. From the total cases, 42 (16.6%) had LVSI and 49 (19.4%) had LUSI. The distribution of the patients included in the study according to their LUSI and LVSI status is given in Table 2 . A total of 19 (7.5%) patients had malignant metastases in the lymph nodes. The distribution of lymph node metastases of patients according to Table 3 . Among the LUSI-positive cases, none of the 31 LVSI-negative cases had metastatic lymph node involvement; however, half of the 18 LVSI-positive cases had metastatic lymph node involvement. This difference was significant (p < 0.05). There was no significant correlation between the LUSI status and lymph node metastasis in LVSI-positive cases (p > 0.05). Lymph node metastases distribution of LUSI-positive patients by LVSI status is given in Table 4 , and the distribution of lymph node metastases of LVSI-positive cases by LUSI status is given in Table 5 . Abdominal irrigation cytology was reported as malignant in only 7 (2.8%) patients. Of the patients with malignant abdominal irrigation cytology, one had LVSI only, three had both LUSI and LVSI, and the remaining patients had neither LUSI nor LVSI. A preoperative CA-125 value was present only in 150 (59.3%) of patients included in the study. In order to approach the mean value of Ca-125 (22.50 U/mL) to 5% trimmed mean value (16.32 U/mL), 4 cases with CA-125 above 130 U/mL were removed, then the calculation was performed and the mean value was found 17.03 ± 15.02. The comparison of the LVSI and LUSI status with the clinical and pathological data is presented in Table 6 .
DISCUSSION
Our study is the first to investigate the correlation of LUSI and LVSI with lymph node involvement and the factors affecting this correlation in patients with endometrioid endometrial carcinoma. The most interesting finding in our study was that of the LUSI-positive cases, none of the 31 LVSI-negative cases had metastatic lymph node involve- There is very little literature on the correlation between LUSI and LVSI. Only Erkaya et al. have investigated the effects of LUSI on survival in endometrial cancer. They examined the effects of LUSI and LVSI as comorbidities on lymph node metastasis and reported that the tumours may have different clinicopathological characteristics due to the differences in lymphatic drainage between the lower and upper segments of the uterus in LUSI-positive patients [19] . Gemer et al. (2009) [20] reported a significant correlation between LUSI and LVSI. In a study by Miyoshi et al. (2018) [21] investigating the prognostic characteristics of lower uterine segment tumors, it was observed that though not significantly, LVSI was more common in the primary tumours of the lower uterine segment. The correlation between the location of the primary tumour and lymph node metastasis was found as significant in the same study. Both positive LUSI and LVSI were significantly associated with lymph node metastasis in our study as well. the patients without involvement in our study. Most of the studies in the literature did not find any significant correlation between age and LUSI [19, 20, 31, 32] . Considering the correlation between patient age and LVSI status, it is seen that there are publications which found both significant [3, 33] and insignificant [27] correlations. Significant correlations have been reported between tumour size, [34, 19] histological grade [19, 33] , and myometrial invasion [19, 20, 33] . These, along with the LUSI and LVSI statuses of patients, affect the decision to proceed with intraoperative lymphadenectomy in endometrial cancer surgery. Furthermore, these correlations were also present in our study.
The limitation of this study is the lack of sufficient information on tumour size, LUSI, and LVSI in some pathology reports, especially between 2010 and 2011. To ensure the exclusion of fewer cases in future studies, a correlation should be established between gynaecological oncologists and pathologists, particularly with regard to the content of the pathology report.
Although a retrospective design was used in this study, we believe that this was compensated for by the fact that 1) the operations were performed by experienced gynaecological oncologists in a single institution, 2) an adequate number of lymph nodes were obtained from all patients undergoing staging surgery, and 3) the operation materials were evaluated by the same gynaecological pathology team.
CONCLUSIONS
We believe that, regarding lymph node metastasis in endometrioid endometrial cancer, LUSI positivity signals the necessity to focus on LVSI. Therefore, in such cases, surgeons should ask for LUSI and LVSI findings from pathologists, in order to facilitate decisions regarding staging surgery.
The correlation between LVSI and pelvic and para-aortic lymph node involvement in endometrial cancer has been known for a long time [22] [23] [24] . However, LVSI is not a direct influence in lymphadenectomy and adjuvant therapy due to a different interpretation of the pathologist and a lack of diagnostic standardization [2, 8] . Furthermore, many pathologists do not focus on LVSI in frozen section examinations as much as they focus on the grade, tumour size, and myometrial invasion. In the study by Vaizoglu et al. (2013) [6] investigating the predictive importance of LVSI in terms of lymph node metastasis in early stage endometrial cancer patients, it was found that LVSI was the only predictive factor for lymph node metastasis, suggesting that pathologists should focus on LVSI in the frozen examination. The compliance rate for LVSI was found to be moderate with 68.3% in a study evaluating the final pathology and frozen section compliance in early stage endometrial cancer cases [25] . The significant correlation between LVSI and lymph node metastasis in LUSI patients suggests that pathologists should also focus on LVSI findings regarding the decision to undergo lymphadenectomy, especially in frozen examinations of cases with endometrial cancer limited to the uterus and lower uterine segment involvement in our study.
The CA-125 values of the patients in our study were significantly higher in both LUSI-and LVSI-positive cases than in the LUSI-and LVSI-negative ones. Although the correlation of endometrial cancer with CA-125 elevation has been known for a long time, [26] we could not find any study evaluating CA-125 level in relation to LVSI and lymph node involvement. One study found no significant correlation between LUSI positivity and CA-125 levels. We found no additional studies on this topic.
In our study, there was no significant correlation between diabetes and neither LVSI nor LUSI. To the best of our knowledge, there is only one study investigating the correlation between LVSI positivity and diabetes in endometrial cancer cases, which found no significant correlation between diabetes and LVSI [27] . We did not find any study directly investigating the correlation between LUSI and diabetes, but we found that there was no significant correlation in an article investigating the correlation between body mass index and LUSI [28] .
In the literature, none of the articles investigating the LUSI or LVSI status in endometrioid endometrial carcinoma cases discussed adenomyosis finding. The reason for investigating adenomyosis in our study is that there are studies suggesting that the coexistence of adenomyosis and endometrioid endometrial cancer may affect the LVSI status [29, 30] . Neither LUSI nor LVSI was significantly correlated with adenomyosis coexistence in our study.
The mean age was significantly higher in both the LUSI-positive group and the LVSI-positive group than
